Monte Rosa Therapeutics Reports Third-Quarter Earnings
Monte Rosa Therapeutics reported third-quarter earnings, according to the headline and available text.
Related stories
Oxford Lane Capital Announces Quarterly NAV, Results and Distributions
Oxford Lane Capital announced net asset value and selected financial results for its second fiscal quarter, and declared common-stock distributions for January, February and March
M impact | EQUITY | Nov 05, 2026, 01:12 PM UTC
Centuri Reports Third-Quarter 2026 Results
Centuri reported third-quarter 2026 results, record quarterly revenue and gross profit, and margin expansion.
M impact | EQUITY | Nov 05, 2026, 01:05 PM UTC
IQSTEL Reports Preliminary Q3 Revenue of $106 Million
IQSTEL said nine-month revenue rose 35% organically to $314 million, equal to 73% of its $430 million 2026 objective. The company also reported preliminary Q3 revenue of $106 milli
M impact | EQUITY | Nov 05, 2026, 01:02 PM UTC
Lipocine Announces Third-Quarter 2026 Financial Results
M impact | EQUITY | Nov 05, 2026, 01:02 PM UTC
NETSOL Technologies Sets Nov. 12 Date for Fiscal Q1 2027 Results
M impact | EQUITY | Nov 05, 2026, 01:01 PM UTC
Acadian Asset Management Reports Third-Quarter Revenue of $191.2M, EPS of $1
Revenue and net income attributable to controlling interests rose year over year, supported by higher average assets under management and increased performance fees. Compensation a
M impact | EQUITY | Nov 05, 2026, 01:01 PM UTC